[Evaluation of Weil-Felix test results by comparing the agglutinability of Proteus OX2 and OX19 commercial antigens: basis for the presumption of a spotted fever group rickettsiosis].
D000372:Agglutination Tests; D000942:Antigens, Bacterial / Q000276:immunology*; D003429:Cross Reactions; D006801:Humans; D011511:Proteus / Q000276:immunology*; D012284:Rickettsia rickettsii / Q000276:immunology; D012373:Rocky Mountain Spotted Fever / Q000175:diagnosis*
D000942:Antigens, Bacterial